S&P 500 7,659.44 −1.09%
Nasdaq 26,140.03 −2.15%
S&P/TSX 36,176.55 +0.11%
Apple 343.46 +0.43%
Nvidia 214.13 −1.43%
Microsoft 529.05 −1.93%
Shopify 239.71 −5.08%
Royal Bank 280.01 +0.36%
CAD/USD 0.7074 +0.40%
AFTER HRS · 19:55 ET
Market ClerkRecap
Fri Oct 16 · after hours3 signals today88 insider buys this week · $104.3MCIRO short report next: Oct 31The week ahead
KP
INSIDER · AGMB · AgomAb Therapeutics NV · CHIEF FINANCIAL OFFICER

Kemula Pierre Thadee Victor

Every open-market transaction filed under this name, Oct 6 to Oct 6.

Filings
3
3 buys · 0 sells
Bought
$86K
open market, at cost
Sold
—
includes scheduled sales
Buys since
−3.1%
avg move from buy price, 3 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 6AGMBAgomAb Therapeutics NVChief Financial OfficerBuy2,000$8.54$17K−2.5%
Oct 6AGMBAgomAb Therapeutics NVChief Financial OfficerBuy5,000$8.57$43K−2.8%
Oct 6AGMBAgomAb Therapeutics NVChief Financial OfficerBuy3,000$8.67$26K−3.9%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.